Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2018 Nov 17;17(5):988–990.e1. doi: 10.1016/j.cgh.2018.11.022

Figure 1.

Figure 1.

(A–D) Endoscopic appearance of patients before receiving tofacitinib (Image order corresponds to patient order where A, Patient 1; B, Patient 2; C, Patient-3; D, Patient 4). (Right) CRP improvement after initiation of tofacitinib. +Indicates when tofacitinib was initiated. *Indicates when the dose of tofacitinib was reduced.